Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer

Luis Felipe Lara Moscoloni; Maximiliano Santarelli; Juan Spagnuolo

doi:10.1016/j.eucr.2021.101629

Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer

Urol Case Rep. 2021 Mar 4:37:101629. doi: 10.1016/j.eucr.2021.101629. eCollection 2021 Jul.

Authors

Luis Felipe Lara Moscoloni¹, Maximiliano Santarelli¹, Juan Spagnuolo¹

Affiliation

¹ Hospital Complejo Medico Churruca - Visca, Buenos Aires, Argentina.

Abstract

Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.

Keywords: Bacillus Calmette-Guérin; Bladder cancer; Non-muscular invasive; Tuberculous epididymo-orchitis.

Publication types

Case Reports